Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Novel drug delivery systems are developed to improve the biological behavior of poorly soluble drugs and to improve therapeutic outcomes. In melanoma therapy, the goal is efficient drug delivery and mitigation of drug resistance. Melphalan (Mel), a currently used therapeutic agent for melanoma, requ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Nanomedicine
Autores principales: Michel, Deborah, Mohammed-Saeid, Waleed, Getson, Heather, Roy, Caitlin, Poorghorban, Masoomeh, Chitanda, Jackson M, Verrall, Ronald, Badea, Ildiko
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://ncbi.nlm.nih.gov/pubmed/28003746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S121156
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares